Company

BRH

BRH

BRH

BRH

Company

About Us

Leading precision drug analysis, empowering global pharmaceutical research and development

Boruiheng Pharmaceutical Technology Co., Ltd. is deeply rooted in Biolake, which is renowned as China's biomedical innovation hub and located in Wuhan East Lake High-tech Development Zone. Since our establishment in 2012, we have remained dedicated to the fields of pharmacokinetic studies, bioequivalence testing, analysis and detection of large/small molecule drugs, committed to establish a one-stop bioanalytical solution that covers the entire “preclinical to clinical studies” chain.
1600

High-standard laboratory

200

Stable strategic partnership

2000 +

Drug Research Project

500 +

Small-molecule drug approach

30 +

Biological macromolecular drug approach

Core advantage

Boasting a 1,600-square-meter, high-standard laboratory that strictly adheres to international GLP guidelines, the CNAS17025 accreditation system, and Biosafety Level 2 (BSL-2) requirements, ensuring both data reliability and experimental safety.

Bringing together experienced, highly skilled professionals who drive project success with a scientific and rigorous approach.

 

Guided by the principles of "Professionalism, Standardization, Collaboration, and Mutual Success," we continuously refine our project management processes, establish a strategic alliance with India’s Pharmazone company, and strengthen our quality management system. We are committed to becoming a globally leading partner in bio- and pharmaceutical analysis services, helping our clients accelerate drug development while jointly shaping a healthier future.

We have established robust strategic partnerships with over 200 renowned pharmaceutical companies, clinical CROs, pharmaceutical CROs, and leading research institutions. Leveraging our strong technical expertise and extensive project experience, Boreiheng has successfully completed more than 2,000 drug research projects to date, developing and validating over 500 small-molecule drug methodologies and more than 30 innovative bio-macromolecule approaches. Our technology platforms now cover over 400 diverse chemical drugs, traditional Chinese medicines, and biologics. At the heart of our operations lies a trusted quality system that ensures excellence—evidenced by our involvement in nearly 30 analytical projects that have seamlessly passed rigorous inspections conducted by the National Medical Products Administration (NMPA). Together, these efforts have helped facilitate the approval and launch of nearly 100 pharmaceutical products, while continuously driving advancements in drug accessibility through our precise and reliable bioanalytical services.

Corporate Culture

Professional, standardized, collaborative, and mutually beneficial

Serving with dedication, putting customers first

Becoming a leading bioanalytical testing company in the industry